Professor Nils Erik Gilhus welcomes Dr Sarah Hoffmann to discuss the challenge of unmet treatment needs in MG, particularly for subgroups under-represented in clinical trials, including those who are older, pregnant, or seronegative.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
